Document ID: s3://data.kl3m.ai/documents/govinfo/USCOURTS/USCOURTS-cand-4_04-cv-05429/USCOURTS-cand-4_04-cv-05429-55/pdf.json

Parties Involved:
Celtrix Pharmaceuticals, Inc.
Counter-claimant
Genentech, Inc.
Counter-defendant
Insmed Incorporated
Counter-claimant
Insmed Therapeutic Proteins
Defendant
Tercica, Inc.
Counter-defendant

Document Text:

MCDERMOTT 

WILL 

& EMERY LLP 

ATTORNEYS AT LAW

PALO ALTO

1 

2 

3 

4 

5 

6 

7 

8 

9 

10 

11 

12 

13 

14 

15 

16 

17 

18 

19 

20 

21 

22 

23 

24 

25 

26 

27 

28 

MPK 118422-1.073241.0011

STIPULATION REGARDING EXHIBITS

CASE NO. C-04-5429 CW (EMC) 

McDERMOTT WILL & EMERY LLP 

WILLIAM G. GAEDE, III (136184) 

wgaede@mwe.com 

TERRENCE P. McMAHON (71910) 

tmcmahon@mwe.com 

ANDREW A. KUMAMOTO (178541) 

akumamoto@mwe.com 

DAVID L. LARSON (112342) 

dlarson@mwe.com 

3150 Porter Drive 

Palo Alto, CA 94304-1212 

Telephone: (650) 813-5000 

Facsimile: (650) 813-5100 

Attorneys for Tercica, Inc. 

HELLER EHRMAN LLP 

M. PATRICIA THAYER (90818) 

patricia.thayer@hellerehrman.com 

ETHAN C. GLASS (216159) 

ethan.glass@hellerehrman.com 

333 Bush Street 

San Francisco, CA 94104-2878 

Telephone: (415) 772-6794 

Facsimile: (415) 772-6268 

Attorneys for Genentech, Inc. 

UNITED STATES DISTRICT COURT 

NORTHERN DISTRICT OF CALIFORNIA 

OAKLAND DIVISION 

GENENTECH, INC., a Delaware 

Corporation, TERCICA, INC., a Delaware 

Corporation, 

Plaintiffs, 

 v. 

INSMED INCORPORATED, a Virginia 

Corporation, and CELTRIX 

PHARMACEUTICALS, INC., a Delaware 

Corporation, INSMED THERAPEUTIC 

PROTEINS, a Colorado Corporation, 

Defendants. 

No. C-04-5429 CW (EMC) 

ORDER GRANTING STIPULATION

REGARDING PLAINTIFFS’ EXHIBITS 

Trial Date: November 6-27, 2006 

Hon. Claudia Wilken 

AND RELATED COUNTERCLAIMS. 

Case 4:04-cv-05429-CW Document 944 Filed 11/20/06 Page 1 of 2
MCDERMOTT 

WILL 

& EMERY LLP 

ATTORNEYS AT LAW

PALO ALTO

1 

2 

3 

4 

5 

6 

7 

8 

9 

10 

11 

12 

13 

14 

15 

16 

17 

18 

19 

20 

21 

22 

23 

24 

25 

26 

27 

28 

MPK 118422-1.073241.0011 1 

STIPULATION REGARDING EXHIBITS

CASE NO. C-04-5429 CW (EMC) 

CASE NO. C-04-5429 CW (EMC)

 Plaintiffs Genentech, Inc. (“Genentech”) and Tercica, Inc. (“Tercica”) (collectively 

“Plaintiffs”) and Defendants Insmed Incorporated, Celtrix Pharmaceuticals, Inc., and Insmed 

Therapeutic Proteins (collectively “Defendants”) hereby stipulate that the following six Exhibits 

are admitted into evidence as part of Plaintiffs’ case in chief: 

 1. PX 155 

 2. PX 218 

 3. PX 245 

 4. PX 252 

 5. PX 257 

 6. PX 267 

SO STIPULATED. 

Dated: November 19, 2006 MCDERMOTT WILL & EMERY LLP 

By: /s/ William G. Gaede, III 

William G. Gaede, III 

 Attorneys for Tercica, Inc. 

 HELLER EHRMAN LLP 

By: /s/ M. Patricia Thayer 

M. Patricia Thayer 

Attorneys for Genentech, Inc. 

 FOLEY & LARDNER, LLP 

 By: /s/ Larry L. Shatzer 

 Larry L. Shatzer 

Attorneys for Insmed Incorporated, Celtrix 

Pharmaceuticals, Inc., and Insmed 

Therapeutic Proteins, Inc. 

-oOoPURSUANT TO STIPULATION, IT IS SO ORDERED. 

Dated: 11/20/06 

HONORABLE CLAUDIA WILKEN 

Judge of the United States District Court 

Case 4:04-cv-05429-CW Document 944 Filed 11/20/06 Page 2 of 2